Contraindications to thrombolytic therapy

Contraindications to thrombolytic therapy for patients with STEMI can be absolute or relative; see Contraindications to thrombolytic therapy in ST elevation myocardial infarction. Patients with an absolute contraindication should be transferred for PCI. For patients with a relative contraindication, consider the risks and benefits of treatment, and seek specialist advice.

Figure 1. Contraindications to thrombolytic therapy in ST elevation myocardial infarction

Absolute contraindications [NB1]

  • any prior intracranial haemorrhage
  • known structural cerebral vascular lesion (eg arteriovenous malformation)
  • known malignant intracranial neoplasm (primary or metastatic)
  • ischaemic stroke within 3 months, except acute ischaemic stroke within 4.5 hours
  • suspected aortic dissection
  • active bleeding or bleeding diathesis (excluding menses)
  • significant closed head or facial trauma within 3 months

Relative contraindications [NB1]

  • history of chronic, severe, poorly controlled elevated blood pressure
  • severely elevated blood pressure on presentation (more than 180 mmHg systolic or more than 110 mmHg diastolic)
  • ischaemic stroke more than 3 months ago, dementia, or known intracranial abnormality not covered as an absolute contraindication
  • traumatic or prolonged (more than 10 minutes) cardiopulmonary resuscitation
  • recent (within 3 weeks) major surgery
  • recent (within 4 weeks) internal bleeding (eg gastrointestinal or urinary tract haemorrhage)
  • noncompressible vascular punctures in the past 24 hours (eg liver biopsy, lumbar puncture)
  • pregnancy or within 1 week postpartum
  • active peptic ulcer disease
  • current use of anticoagulants
  • advanced liver disease
  • infective endocarditis
  • transient ischaemic attack in the preceding 6 months
Note:

NB1: This is not an exhaustive list; assess each patient individually.

Source: O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr., Chung MK, de Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127(4):e362-425. URL